Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Roberge, Guillaume; Carrier, Marc

Roberge, Guillaume; Carrier, Marc.

Roberge G; Department of Medicine, 36896Centre Hospitalier Universitaire de Québec, Université Laval, Hôpital Saint-François d'Assise, Québec, Canada.
Carrier M; Department of Medicine, 10055Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada.

Clin Appl Thromb Hemost ; 28: 10760296221086283, 2022.

Article in English | MEDLINE | ID: covidwho-1741847

Subject(s)

COVID-19; ChAdOx1 nCoV-19; Platelet Activation; Purpura, Thrombotic Thrombocytopenic; SARS-CoV-2/immunology; Anticoagulants/administration & dosage; Anticoagulants/adverse effects; COVID-19/immunology; COVID-19/prevention & control; ChAdOx1 nCoV-19/administration & dosage; ChAdOx1 nCoV-19/adverse effects; ChAdOx1 nCoV-19/immunology; Female; Humans; Male; Platelet Activation/drug effects; Platelet Activation/immunology; Purpura, Thrombotic Thrombocytopenic/chemically induced; Purpura, Thrombotic Thrombocytopenic/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Platelet Activation / SARS-CoV-2 / COVID-19 / ChAdOx1 nCoV-19 Topics: Vaccines Limits: Female / Humans / Male Language: English Journal: Clin Appl Thromb Hemost Journal subject: Vascular Diseases Year: 2022 Document Type: Article Affiliation country: 10760296221086283

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google